4
S. G. Davies et al. / Tetrahedron: Asymmetry xxx (2017) xxx–xxx
hydroxamate is consistent with highly selective conjugate addition
of lithium amide reagents on the face opposite to both the O-tert-
butyl group and nitrogen lone-pair, as observed experimentally.
CH2Cl2 (4 mL). Purification via flash column chromatography (gra-
dient elution, 1% ? 20% Et2O in 30–40 °C petrol) gave 15 as a white
solid (190 mg, 65%); mp 98–100 °C; ½a D25
ꢂ26.9 (c 1.0 in CHCl3);
ꢄ
mmax (KBr) 1649 (C@O), 1624 (C@C); dH (500 MHz, PhMe-d8,
343 K) 0.75 (9H, s, CMe3), 1.78 (3H, d, J 6.9, C(100)Me), 6.43–6.63
(1H, br m, C(100)H), 6.69–6.78 (1H, m, Ar), 6.99–7.54 (7H, m, C(2)
H, Ar), 7.56–7.68 (3H, m, Ar), 7.71 (1H, d, J 15.8, C(3)H), 8.55–
8.77 (1H, br m, Ar); dC (125 MHz, CDCl3) 16.4 (C(100)Me), 27.8
(CMe3), 55.8 (C(100)), 83.0 (CMe3), 121.5, 123.7, 124.4, 124.9,
125.6, 125.7, 126.1, 126.6, 127.5, 128.6, 132.6, 133.3, 133.5,
133.6, 135.3, 136.0 (Ar), 130.7 (C(2)), 141.4 (C(3)), 173.1 (C(1));
m/z (ESI+) 927 ([M(79Br)+M(81Br)+Na]+, 100%), 476 ([M(81Br)
+Na]+, 50%), 474 ([M(79Br)+Na]+, 50%); HRMS (ESI+)
4. Experimental
All reagents were used as supplied without prior purification.
Melting points were recorded on a Gallenkamp Hot Stage appara-
tus and are uncorrected. IR spectra were recorded on a Bruker Ten-
sor 27 FT-IR spectrometer as KBr discs. Selected characteristic
peaks are reported in cmꢂ1. NMR spectra were recorded on Bruker
Avance spectrometers in the deuterated solvent stated. Spectra
were recorded at rt. The field was locked by external referencing
to the relevant deuteron resonance. Low-resolution mass spectra
were recorded on either a VG MassLab 20–250 or a Micromass
Platform 1 spectrometer. Accurate mass measurements were run
on a Micromass GCT instrument fitted with a Scientific Glass
Instruments BPX5 column (15 m ꢃ 0.25 mm) using amyl acetate
as a lock mass.
C25H2681BrNNaO2 ([M(81Br)+Na]+) requires 476.1020; found
+
476.1024; HRMS (ESI+) C25H2679BrNNaO2+ ([M(79Br)+Na]+) requires
474.1039; found 474.1031.
4.4. (S)-N-tert-Butoxy-N-100-(1000-naphthyl)ethyl (E)-3-(40-bromo-
phenyl)propenamide 16
Following the general procedure, a solution of trans-4-bromocin-
namic acid 13 (300 mg, 1.32 mmol) in CH2Cl2 (3 mL) was reacted
with (COCl)2 (0.18 mL, 2.11 mmol) and a mixture of (S)-17ꢁ(+)-
CSA1 (250 mg, 0.52 mmol) and K2CO3 (725 mg, 5.25 mmol) in
CH2Cl2 (3 mL). Purification via flash column chromatography (gra-
dient elution, 1% ? 20% Et2O in 30–40 °C petrol) gave 16 as a white
4.1. General procedure
A solution of the requisite carboxylic acid (2.5 equiv) in CH2Cl2
at 0 °C was treated with (COCl)2 (5.0 equiv) and DMF (1 drop). The
reaction mixture was allowed to warm to rt over 1 h then concen-
trated in vacuo. The residue was dissolved in CH2Cl2 and the resul-
tant mixture was added to a stirred solution of (S)-17ꢁ(+)-CSA1
(1.0 equiv) and K2CO3 (10.0 equiv) in CH2Cl2 at 0 °C. The reaction
mixture was then allowed to warm to rt and stirred at rt for
18 h. Satd aq NaHCO3 was then added and the resultant mixture
was extracted with three portions of CH2Cl2. The combined organic
extracts were washed with brine, then dried and concentrated in
vacuo.
solid (96 mg, 42%); mp 102–104 °C; ½a D25
ꢄ
–17.2 (c 0.5 in CHCl3);
mmax (KBr) 1654 (C@O), 1616 (C@C); dH (500 MHz, PhMe-d8,
343 K) 0.77 (9H, s, CMe3), 1.76 (3H, d, J 6.9, C(100)Me), 6.47–6.63
(1H, br m, C(100)H), 6.92–7.32 (7H, m, C(2)H, Ar), 7.39–7.49 (1H,
m, Ar), 7.56–7.68 (3H, m, Ar), 7.75 (1H, d, J 15.8, C(3)H), 8.53–
8.78 (1H, br m, Ar); dC (125 MHz, CDCl3) 16.3 (C(100)Me), 27.8
(CMe3), 55.7 (C(100)), 83.1 (CMe3), 119.4 (C(2)), 124.0, 124.4,
124.9, 125.7, 126.1, 126.5, 128.6, 129.1, 129.4, 132.1, 132.6,
133.6, 134.2, 136.0 (Ar), 141.7 (C(3)), 173.3 (C(1)); m/z (ESI+) 476
([M(81Br)+Na]+, 100%), 474 ([M(79Br)+Na]+, 100%); HRMS (ESI+)
4.2.
bromophenyl)propenamide 14
(S)-N-tert-Butoxy-N-100-(1000-naphthyl)ethyl
(E)-3-(20-
C
25H2681BrNNaO+2 ([M(81Br)+Na]+) requires 476.1020; found
476.1010; HRMS (ESI+) C25H2679BrNNaO+2 ([M(79Br)+Na]+) requires
474.1039; found 474.1021.
Following the general procedure, a solution of trans-2-bromocin-
namic acid 11 (1.20 g, 5.25 mmol) in CH2Cl2 (12 mL) was reacted
with (COCl)2 (0.71 mL, 8.40 mmol) and a mixture of (S)-17ꢁ(+)-
CSA1 (1.00 g, 2.10 mmol) and K2CO3 (2.90 g, 21.0 mmol) in CH2Cl2
(10 mL). Purification via flash column chromatography (gradient
elution, 1% ? 20% Et2O in 30–40 °C petrol) gave 14 as a white solid
4.5. Single crystal X-ray diffraction
Single crystal diffraction data for 14–16 were collected using a
(665 mg, 70%); mp 110–112 °C; ½a D25
ꢄ
ꢂ56.9 (c 1.0 in CHCl3); mmax
Nonius
j-CCD diffractometer (Mo-Ka radiation, k = 0.71073 Å) at
150(2) K with an Oxford Cryosystems Cryostream N2 open-flow
cooling device16 and processed using the DENZO-SMN package,17
including unit cell parameter refinement and inter-frame scaling
(which were carried out using SCALEPACK within DENZO-SMN).
The structures were solved using SIR92.18 Refinement was car-
ried out using full-matrix least-squares within the CRYSTALS
suite,19 on F2. All non-hydrogen atoms were refined with anisotro-
pic displacement parameters. The positions and isotropic displace-
ment parameters of hydrogen atoms were refined using restraints
prior to inclusion into the model with riding constraints.20 For all
structures the Flack x parameter13,14 was refined and was found
to satisfy the criteria for a reliable assignment of absolute configu-
ration of a material known to be enantiopure.
(KBr) 1650 (C@O), 1612 (C@C); dH (500 MHz, PhMe-d8, 343 K)
0.76 (9H, s, CMe3), 1.76 (3H, d, J 6.9, C(100)Me), 6.46–6.58 (1H, br
m, C(100)H), 6.67–6.73 (1H, m, Ar), 6.83–6.89 (1H, m, Ar), 6.98–
7.45 (6H, m, C(2)H, Ar), 7.58–7.67 (3H, m, Ar), 8.41 (1H, d, J 15.8,
C(3)H), 8.56–8.74 (1H, br m, Ar); dC (125 MHz, CDCl3) 16.3
(C(100)Me), 27.8 (CMe3), 55.8 (C(100)), 83.1 (CMe3), 120.2, 123.0,
124.4, 124.9, 125.7, 126.1, 126.6, 126.8, 128.6, 130.6, 132.6,
133.6, 136.0, 137.2, 137.5 (Ar), 130.4 (C(2)), 141.4 (C(3)), 173.1
(C(1)); m/z (ESI+) 927 ([M(79Br)+M(81Br)+Na]+, 100%), 476
([M(81Br)+Na]+, 50%), 474 ([M(79Br)+Na]+, 50%); HRMS (ESI+)
+
C
25H2681BrNNaO2 ([M(81Br)+Na]+) requires 476.1020; found
476.1010; HRMS (ESI+) C25H2679BrNNaO2+ ([M(79Br)+Na]+) requires
474.1039; found 474.1024.
4.3.
bromophenyl)propenamide 15
(S)-N-tert-Butoxy-N-100-(1000-naphthyl)ethyl
(E)-3-(30-
Supplementary data
Full crystallographic data for 14–16 have been deposited with
the Cambridge Crystallographic Data Centre as supplementary
publication numbers CCDC 817636, 817637 and 817638, respec-
tively. Copies of these data can be obtained free of charge from
Following the general procedure, a solution of trans-3-bromocin-
namic acid 12 (400 mg, 1.76 mmol) in CH2Cl2 (4 mL) was reacted
with (COCl)2 (0.24 mL, 2.82 mmol) and a mixture of (S)-17ꢁ(+)-
CSA1 (336 mg, 0.70 mmol) and K2CO3 (974 mg, 7.04 mmol) in